Literature DB >> 15811349

PICK-1: a scaffold protein that interacts with Nectins and JAMs at cell junctions.

Nicolas Reymond1, Sarah Garrido-Urbani, Jean-Paul Borg, Patrice Dubreuil, Marc Lopez.   

Abstract

Nectin adhesion molecules are involved in the early steps of cell junction formation. Later during the polarisation process, Nectins are components of epithelial adherens junctions where they are indirectly associated with the E-cadherin/Catenins complex via the adaptator AF-6. To have a better understanding of Nectin-based cell junctions, we looked for some new Nectins' partners. We demonstrate that the scaffold molecule PICK-1, involved in the clustering of junctional receptors in synaptic junctions, interacts directly with Nectins in a PSD-95/Dlg/ZO-1 domain-dependent manner and is localised at adherens junctions in epithelial cells. Finally, we observed that protein interacting with C-kinase-1 (PICK-1) also interacts directly with the junctional adhesion molecules, and we suggest that PICK-1 could be involved in the regulation of both adherens and tight junctions in epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15811349     DOI: 10.1016/j.febslet.2005.03.010

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  PDZ binding to the BAR domain of PICK1 is elucidated by coarse-grained molecular dynamics.

Authors:  Yi He; Adam Liwo; Harel Weinstein; Harold A Scheraga
Journal:  J Mol Biol       Date:  2010-11-02       Impact factor: 5.469

Review 2.  Junctional adhesion molecule-A: functional diversity through molecular promiscuity.

Authors:  Tim Steinbacher; Daniel Kummer; Klaus Ebnet
Journal:  Cell Mol Life Sci       Date:  2017-12-14       Impact factor: 9.261

Review 3.  Cellular and pathophysiological consequences of Arp2/3 complex inhibition: role of inhibitory proteins and pharmacological compounds.

Authors:  Sandra Chánez-Paredes; Armando Montoya-García; Michael Schnoor
Journal:  Cell Mol Life Sci       Date:  2019-05-09       Impact factor: 9.261

4.  Genetic deletion of JAM-C reveals a role in myeloid progenitor generation.

Authors:  Asja Praetor; Jacqueline M McBride; Henry Chiu; Linda Rangell; Lorena Cabote; Wyne P Lee; James Cupp; Dimitry M Danilenko; Sherman Fong
Journal:  Blood       Date:  2008-12-24       Impact factor: 22.113

Review 5.  Protein kinase C family: on the crossroads of cell signaling in skin and tumor epithelium.

Authors:  D Breitkreutz; L Braiman-Wiksman; N Daum; M F Denning; T Tennenbaum
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-28       Impact factor: 4.553

Review 6.  Cross-talk between tight and anchoring junctions-lesson from the testis.

Authors:  Helen H N Yan; Dolores D Mruk; Will M Lee; C Yan Cheng
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

7.  JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/β-catenin/CCND1 signaling.

Authors:  Yaping Zhang; Fangzhen Xia; Xiaoye Liu; Zhuo Yu; Li Xie; Ligen Liu; Chiqi Chen; Haishan Jiang; Xiaoxin Hao; Xiaoxiao He; Feifei Zhang; Hao Gu; Jun Zhu; Haitao Bai; Cheng Cheng Zhang; Guo-Qiang Chen; Junke Zheng
Journal:  J Clin Invest       Date:  2018-03-26       Impact factor: 14.808

8.  PLEKHA7 Recruits PDZD11 to Adherens Junctions to Stabilize Nectins.

Authors:  Diego Guerrera; Jimit Shah; Ekaterina Vasileva; Sophie Sluysmans; Isabelle Méan; Lionel Jond; Ina Poser; Matthias Mann; Anthony A Hyman; Sandra Citi
Journal:  J Biol Chem       Date:  2016-04-04       Impact factor: 5.157

Review 9.  Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii.

Authors:  C J Carter
Journal:  Schizophr Bull       Date:  2008-06-13       Impact factor: 9.306

10.  Nectin-3 (CD113) interacts with Nectin-2 (CD112) to promote lymphocyte transendothelial migration.

Authors:  Elisabeth Devilard; Luc Xerri; Patrice Dubreuil; Marc Lopez; Nicolas Reymond
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.